Join to View Full Profile
1601 Trinity StAustin, TX 78712
Phone+1 512-495-5512
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sue Eckhardt, MD is an oncologist in Austin, Texas. She is currently licensed to practice medicine in Texas, Colorado, and California.
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Medical Oncology, 1988 - 1990
- University of Virginia Medical CenterInternship, Internal Medicine, 1985 - 1986
- University of Texas Medical Branch School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1988 - Present
- TX State Medical License 1993 - 2026
- CO State Medical License 1999 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress.Milad Soleimani, Mark Duchow, Ria Goyal, Alexander Somma, Tamer S Kaoud
Life Science Alliance. 2025-03-01 - The Oncology Industrial Complex-Community Oncology Must Be Given a Seat at the Table-Reply.S Gail Eckhardt, Leonidas C Platanias
JAMA Oncology. 2025-02-27 - 1 citationsPromoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers.Eric P Winer, Laura A Levit, Ethan Basch, Mariana Chavez-MacGregor, Ray Dubois
Journal of Clinical Oncology. 2025-02-10
Press Mentions
- “It’s Dire”: Unprecedented Oncologist Faculty Departures Prompt ASCO ResponseApril 14th, 2025
- Houston Cancer-Fighting Organization Launches Center to Support Early TrialsSeptember 3rd, 2024
- Dan L Duncan Comprehensive Cancer Center Launches Phase 1 Clinical Trial ProgramAugust 19th, 2024